SOLY News and Press, Soliton Inc. From 05/16/19

May 16, 2019 Palm Beach, FL –May 16, 2019 –  The initial diagnosis and the 2 nd opinions all show that the global medical device markets are projected to have a very healthy revenue prognosis through 2014.  In the 2018 edition of the EvaluateMedTech® ...

HOUSTON , May 16, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today discu...

PALM BEACH, Florida , May 14, 2019 /PRNewswire/ -- The U.S. is a global leader in technology. The U.S. is also historically where innovation is always at the forefront… so it is no surprise that the U.S. Medical Device market… a marriage of technology and innovation… ...

HOUSTON , May 14, 2019 /PRNewswire/ -- Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today annou...

Gainers:  Cellectar Biosciences (NASDAQ: CLRB ) +7% . More news on: Cellectar Biosciences, Inc., INSYS Therapeutics, Inc., Soliton, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Soliton ( SOLY ) is a small medical device company established in 2012. The company, which is pre-revenue, is developing the Rapid Acoustic Pulse ((RAP)) technology that is aimed at the tattoo industry. If accepted by the Food and Drug Administration (FDA), the device will help improve the tat...

Soliton, Inc. ( SOLY ) is a company currently conducting research for its acoustic shockwave technology. The company claims that the technology has uses in multiple billion-dollar industries. As of this time, the company is utilizing its technology in the development of a Rapid Acoustic Puls...

May 1, 2019 Palm Beach, FL –May 1, 2019 – The consumer demand for a solution to cellulite has been growing for years. Cellulite is a cosmetic problem, not a disease process. It affects 85% to 90% of all women worldwide and 10% of men. A recent article titled “Cel...

HOUSTON , May 1, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announ...

Biotech Brief: Optimistic Outlook Growing for Multi-Billion Dollar Medical Device Industry April 23, 2019 Palm Beach, FL –April 23, 2019 – A recent industry article reported on an optimistic overview concerning the Medical Device Industry. It said: “The medical...